Muscle MRI in motor neuron diseases: a systematic review

References

• Morrow JM, Sinclair CDJ, Fischmann A, Machado PM, Reilly MM, Yousry TA, et al. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. Lancet Neurol. 2016;15:65–77.
   PubMed Web of Science ®Google Scholar
• Carlier PG, Reyngoudt H. The expanding role of MRI in neuromuscular disorders. Nat Rev Neurol. 2020;16:301–2.
   PubMed Web of Science ®Google Scholar
• Müller M, Dohrn MF, Romanzetti S, Gadermayr M, Reetz K, Krämer NA, et al. Semi-automated volumetry of MRI serves as a biomarker in neuromuscular patients. Muscle Nerve. 2020;61:600–7.
   PubMed Web of Science ®Google Scholar
• Dahlqvist JR, Widholm P, Leinhard OD, Vissing J. MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy. Ann Neurol. 2020;88:669–81.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psychiatry. 2005;77:390–2.
   Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Zucchi E, Bonetto V, Sorarù G, Martinelli I, Parchi P, Liguori R, et al. Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Mol Neurodegener. 2020;15: 58.
   PubMed Web of Science ®Google Scholar
• Poesen K, Van Damme P. Diagnostic and prognostic performance of neurofilaments in ALS. Front Neurol. 2019;9:1–7.
   Web of Science ®Google Scholar
• Majumder V, Gregory JM, Barria MA, Green A, Pal S. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis. BMC Neurol. 2018;18:1–7.
   PubMed Web of Science ®Google Scholar
• Verber NS, Shepheard SR, Sassani M, McDonough HE, Moore SA, Alix JJP, et al. Biomarkers in motor neuron disease: a state of the art review. Front Neurol. 2019;10:1–28.
   PubMed Web of Science ®Google Scholar
• Neuwirth C, Nandedkar S, Stålberg E, Weber M. Motor Unit Number Index (MUNIX): a novel neurophysiological technique to follow disease progression in amyotrophic lateral sclerosis. Muscle Nerve. 2010;42:379–84.
   PubMed Web of Science ®Google Scholar
• Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler. 2012;13:439–45.
   PubMed Web of Science ®Google Scholar
• NHLBI. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies [Internet]. 2014. p. 1–4. Available at: https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/cohort. Accessed February 9, 2021.
   Google Scholar
• Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
   Google Scholar
• Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Cross sectional study newcastle – Ottawa quality assessment scale. PLoS One 2016;11:1–2.
   Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMed Web of Science ®Google Scholar
• Cha CH, Patten BM. Amyotrophic lateral sclerosis: abnormalities of the tongue on magnetic resonance imaging. Ann Neurol. 1989;25:468–72.
   PubMed Web of Science ®Google Scholar
• Bryan WW, Reisch JS, McDonald G, Herbelin LL, Barohn RJ, Fleckenstein JL. Magnetic resonance imaging of muscle in amyotrophic lateral sclerosis. Neurology. 1998;51:110–3.
   PubMed Web of Science ®Google Scholar
• Hamano T, Mutoh T, Hirayama M, Kawamura Y, Nagata M, Fujiyama J, et al. Muscle MRI findings of X-linked spinal and bulbar muscular atrophy. J Neurol Sci. 2004;222:93–7.
   PubMed Web of Science ®Google Scholar
• Kronlage M, Knop KC, Schwarz D, Godel T, Heiland S, Bendszus M, et al. Amyotrophic lateral sclerosis versus multifocal motor neuropathy: utility of MR neurography. Radiology. 2019;292:149–56.
   PubMed Web of Science ®Google Scholar
• Hensiek N, Schreiber F, Wimmer T, Kaufmann J, Machts J, Fahlbusch L, et al. Sonographic and 3T-MRI-based evaluation of the tongue in ALS. Neuroimage Clin. 2020;26:102233.
   PubMed Web of Science ®Google Scholar
• Lee E, Xing F, Ahn S, Reese TG, Wang R, Green JR, et al. Magnetic resonance imaging based anatomical assessment of tongue impairment due to amyotrophic lateral sclerosis: a preliminary study. J Acoust Soc Am. 2018;143:EL248.
   PubMed Web of Science ®Google Scholar
• Jenkins TM, Burness C, Connolly DJ, Rao DG, Hoggard N, Mawson S, et al. A prospective pilot study measuring muscle volumetric change in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:414–23.
   PubMed Web of Science ®Google Scholar
• Staff NP, Amrami KK, Howe BM. Magnetic resonance imaging abnormalities of peripheral nerve and muscle are common in amyotrophic lateral sclerosis and share features with multifocal motor neuropathy. Muscle Nerve. 2015;52:137–9.
   PubMed Web of Science ®Google Scholar
• Gerevini S, Agosta F, Riva N, Spinelli EG, Pagani E, Caliendo G, et al. MR imaging of brachial plexus and limb-girdle muscles in patients with amyotrophic lateral sclerosis. Radiology. 2016;279:553–61.
   PubMed Web of Science ®Google Scholar
• Jenkins TM, Alix JJPP, David C, Pearson E, Rao DG, Hoggard N, et al. Imaging muscle as a potential biomarker of denervation in motor neuron disease. J Neurol Neurosurg Psychiatry. 2018;89:248–55.
   PubMed Web of Science ®Google Scholar
• Diamanti L, Alfonsi E, Ferraro OE, Cereda C, Pansarasa O, Bastianello S, et al. A pilot study assessing T1-weighted muscle MRI in amyotrophic lateral sclerosis (ALS). Skeletal Radiol. 2019;48:569–75.
   PubMed Web of Science ®Google Scholar
• Klickovic U, Zampedri L, Sinclair CDJJ, Wastling SJ, Trimmel K, Howard RS, et al. Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity. Neurology. 2019;93:E895–907.
   PubMed Web of Science ®Google Scholar
• Diamanti L, Paoletti M, Vita U, Di Muzic SI, Cereda C, Ballante E, et al. MRI study of paraspinal muscles in patients with amyotrophic lateral sclerosis (ALS). J Clin Med. 2020;9: 934.
   Web of Science ®Google Scholar
• Jenkins TM, Alix JJPP, Fingret J, Esmail T, Hoggard N, Baster K, et al. Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease. J Neurol. 2020;267:244–56.
   PubMed Web of Science ®Google Scholar
• Sproule DM, Punyanitya M, Shen W, Dashnaw S, Martens B, Montgomery M, et al. Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. J Child Neurol. 2011;26:309–17.
   PubMed Web of Science ®Google Scholar
• Sproule DM, Montgomery MJ, Punyanitya M, Shen W, Dashnaw S, Montes J, et al. Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy. J Child Neurol. 2011;26:1252–9.
   PubMed Web of Science ®Google Scholar
• Souza PVS, Pinto WBVR, Ricarte A, Badia BML, Seneor DD, Teixeira DT, et al. Clinical and radiological profile of patients with spinal muscular atrophy type 4. Eur J Neurol. 2021;28:609–19.
   PubMed Web of Science ®Google Scholar
• Bonati U, Holiga Š, Hellbach N, Risterucci C, Bergauer T, Tang W, et al. Longitudinal characterization of biomarkers for spinal muscular atrophy. Ann Clin Transl Neurol. 2017;4:292–304.
   PubMed Web of Science ®Google Scholar
• Mercuri E, Messina S, Kinali M, Cini C, Longman C, Battini R, et al. Congenital form of spinal muscular atrophy predominantly affecting the lower limbs: a clinical and muscle MRI study. Neuromuscul Disord. 2004;14:125–9.
   PubMed Web of Science ®Google Scholar
• Durmus H, Yilmaz R, Gulsen-Parman Y, Oflazer-Serdaroglu P, Cuttini M, Dursun MM. u, et al. Muscle magnetic resonance imaging in spinal muscular atrophy type 3: selective and progressive involvement. Muscle Nerve. 2017;55:651–6.
   PubMed Web of Science ®Google Scholar
• Kollmer J, Hilgenfeld T, Ziegler A, Saffari A, Sam G, Hayes JM, et al. Quantitative MR neurography biomarkers in 5q-linked spinal muscular atrophy. Neurology. 2019;93:e653–e664.
   PubMed Web of Science ®Google Scholar
• Barp A, Carraro E, Albamonte E, Salmin F, Lunetta C, Comi GP, et al. Muscle MRI in two SMA patients on nusinersen treatment: a two years follow-up. J Neurol Sci. 2020;417:117067.
   PubMed Web of Science ®Google Scholar
• Brogna C, Cristiano L, Verdolotti T, Pichiecchio A, Cinnante C, Sansone V, et al. MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients. J Neurol. 2020;267:898–912.
   PubMed Web of Science ®Google Scholar
• Liu GC, Jong YJ, Chiang CH, Yang CW. Spinal muscular atrophy: MR evaluation. Pediatr Radiol. 1992;22:584–6.
   PubMed Web of Science ®Google Scholar
• Otto LAM, van der Pol WL, Schlaffke L, Wijngaarde CA, Stam M, Wadman RI, et al. Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3. NMR Biomed. 2020;33:1–13.
   Web of Science ®Google Scholar
• Otto LAM, Froeling M, van Eijk RPA, Asselman FL, Wadman R, Cuppen I, et al. Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study. NMR Biomed. 2021;34:1–11.
   Web of Science ®Google Scholar
• Savini G, Asteggiano C, Paoletti M, Parravicini S, Pezzotti E, Solazzo F, et al. Pilot study on quantitative cervical cord and muscular MRI in spinal muscular atrophy: promising biomarkers of disease evolution and treatment? Front Neurol. 2021;12:1–18.
   Web of Science ®Google Scholar
• Dahlqvist JR, Oestergaard ST, Poulsen NS, Thomsen C, Vissing J. Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments. Neurology. 2019;92:e548–e559.
   PubMed Web of Science ®Google Scholar
• Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, Counsell S, et al. Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul Disord. 2002;12:631–8.
   PubMed Web of Science ®Google Scholar
• Gaeta M, Mileto A, Mazzeo A, Minutoli F, Di Leo R, Settineri N, et al. MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease. Skeletal Radiol. 2012;41:515–24.
   PubMed Web of Science ®Google Scholar
• Fischer D, Kley RA, Strach K, Meyer C, Sommer T, Eger K, et al. Distinct muscle imaging patterns in myofibrillar myopathies. Neurology. 2008;71:758–65.
   PubMed Web of Science ®Google Scholar
• Stramare R, Beltrame V, Dal Borgo R, Gallimberti L, Frigo AC, Pegoraro E, et al. La risonanza magnetica nella valutazione delle patologie muscolari: confronto tra distrofia dei cingoli, miopatia a corpi ialini e distrofia miotonica. Radiol Med. 2010;115:585–99.
   PubMed Web of Science ®Google Scholar
• Simon NG. Pragmatic approach to muscle MRI biomarkers in motor neuron disease. J Neurol Neurosurg Psychiatry. 2018;89:230.
   PubMed Web of Science ®Google Scholar